Jefferies maintained a Buy rating on Exact Sciences (NASDAQ: EXAS), and cut the price target to $13.00 (from $15.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change

Stephens Downgrades Exact Sciences (EXAS) to Equal WeightFebruary 25, 2016 7:55 AM Roth Capital Downgrades Exact Sciences (EXAS) to NeutralFebruary 25, 2016 6:56 AM Anthem BCBS Georgia and Virginia Contracted to Cover Cologuard as In-Network ServiceFebruary 25, 2016 6:00 AM Craig-Hallum Downgrades Exact Sciences (EXAS) to HoldFebruary 24, 2016 1:37 PM Exact Sciences (EXAS) Tops Q4 EPS by 6c, Maintains Cologuard OutlookFebruary 24, 2016 7:31 AM Exact Sciences Reports Fourth Quarter and Full Year 2015 ResultsFebruary 24, 2016 6:00 AM Trading Radar for 2/24: Lowe's (LOW), salesforce (CRM), Target (TGT), MobilEye (MBLY), Rubicon Tech (RBCN) ReportFebruary 23, 2016 2:43 PM Modeling Data Supports Cologuard Use Every Three YearsFebruary 23, 2016 6:37 AM